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Abstract
Background: Primary health care (PHC) settings offer opportunities for tobacco use screening and brief cessation
advice, but data on such activities in South Africa are limited. The aim of this study was to determine the extent to
which participants were screened for and advised against tobacco use during consultations.
Methods: This cross-sectional study involved 500 participants, 18 years and older, attended by doctors or PHC
nurses. Using an exit-interview questionnaire, information was obtained on participants’ tobacco use status, reason
(s) for seeking medical care, whether participants had been screened for and advised about their tobacco use and
patients’ level of comfort about being asked about and advised to quit tobacco use. Main outcome measures
included patients’ self-reports on having been screened and advised about tobacco use during their current clinic
visit and/or any other visit within the last year. Data analysis included the use of chi-square statistics, t-tests and
multiple logistic regression analysis.
Results: Of the 500 participants, 14.9% were current smokers and 12.1% were smokeless tobacco users. Only 12.9%
of the participants were screened for tobacco use during their current visit, indicating the vast majority were not
screened. Among the 134 tobacco users, 11.9% reported being advised against tobacco use during the current
visit and 35.1% during any other visit within the last year. Of the participants not screened, 88% indicated they
would be ‘very comfortable’ with being screened. A pregnancy-related clinic visit was the single most significant
predictor for being screened during the current clinic visit (OR = 4.59; 95%CI = 2.13-9.88).
Conclusion: Opportunities for tobacco use screening and brief cessation advice were largely missed by clinicians.
Incorporating tobacco use status into the clinical vital signs as is done for pregnant patients during antenatal care
visits in South Africa has the potential to improve tobacco use screening rates and subsequent cessation.
Background
Tobacco is the single most significant cause of preventa-
ble morbidity and mortality globally [1]. The last South
African Demography and Health Survey (SADHS) of
2003 reported a cigarette smoking prevalence of 35%
among men and 10% among women. In the same
report, 3% of men had ever used smokeless tobacco
(SLT), compared to 12% of women. Although fewer
Black South Africans smoke cigarettes compared to
other racial groups, the majority of SLT users were
Black women [2].
The health implications of tobacco use are well docu-
mented and include deaths attributable to direct smok-
ing, passive smoking and the use of SLT [3]. Smoking
currently accounts for 8% to 9% of all deaths in South
Africa; and tobacco use is ranked third, after unsafe sex
and high blood pressure, as the most important of 17
evaluated risk factors for mortality in South Africa [4].
Irrespective of the form in which users use tobacco,
complete cessation reduces the risks associated with
tobacco use [5-8].
Primary health care (PHC) is the most common set-
ting for the provision of tobacco cessation advice [9].
Clinicians at this level of health care are well placed to
use every patient contact as an opportunity for screen-
ing patients for and advisingt h e ma g a i n s tt o b a c c ou s e .
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smoking status of their patients in only 66% of patient
visits; and generalists felt more confident and more fre-
quently offered cessation advice than specialists (22% vs
10%) [10]. In another study in the USA, the counseling
behavior of physicians was associated with clinicians’
perception of clinical relevance [11]. In the South Afri-
can PHC context, however, the available literature
(which is very limited) suggests that doctors do not
intervene in their patients’ tobacco use habits [12].
Brief cessation advice improves cessation rates [13]
and has been recommended as part of the clinical prac-
tice guideline for the management of tobacco depen-
dence [14]. The World Health Organization’s( W H O )
Framework Convention for Tobacco Control (FCTC) -
of which South Africa is a signatory, expects signatories
to provide tobacco dependence treatment/cessation ser-
vices [15]. Although patients consider their family doc-
tor a key influence and a source of advice on smoking,
[16] many doctors focus on the presenting clinical pro-
blem(s) and are reluctant to use their influence to
encourage health-promoting behaviors in the absence of
disease, including intervening in a patient’s tobacco use
[12]. This behavior has serious implications for South
Africa, in that its overstretched health system (mainly
due to the HIV/AIDS and TB pandemics) can hardly
afford the additional increased burden of tobacco-attri-
butable diseases.
Tobacco use is highly prevalent in South Africa. It
thus necessitates intensive and sustained interventions,
which include ongoing PHC screening and counseling.
The clinical consultation in PHC provides opportunities
for these activities. However, PHC clinicians’ tobacco
use screening behavior is hardly documented in South
Africa and the only available literature suggests that
doctors in South Africa are not intervening in their
patients’ tobacco use habits [12]. This article reports on
the extent to which tobacco use screening is done and
the proportion of tobacco users provided with cessation
advice in a South African PHC setting, highlighting the
implications for tobacco control in the country.
Methods
Design and research setting
This cross-sectional study was conducted among
patients 18 years and older attending a large Commu-
nity Health Centre in South Africa during September
2008. This health facility provides a full range of cura-
tive services (including obstetric services), health promo-
tion and rehabilitation services to a target population of
approximately 75 000 and manages about 5 500 adult
patients per month. The health care services are pro-
vided by six PHC nurse clinicians and three PHC doc-
tors. In this facility, nurse clinicians dispense medication
in their consulting rooms, while doctors’ prescriptions
are dispensed by pharmacists in the Centre’s pharmacy.
Recruitment of participants’ and consent
As a m p l es i z eo f3 6 0w a sc a l c u l a t e dt ob ea d e q u a t e ,
based on a margin of error of 5%, a confidence level of
95% and a response distribution of 50% [17]. However,
500 participants were recruited to compensate for possi-
ble incomplete data.
Consecutive patients were invited to participate in the
study after they had exited from the consulting rooms
where they were attended to. Patients attended by
nurses, and doctors’ patients whose visits did not result
in prescriptions were processed in a room next to the
one where patients return their files, to minimize inter-
ruptions in patient flow. Patients attended by doctors
who had written prescriptions were processed in the
pharmacy waiting room to minimize interruptions and
delays in patient flow. In both instances, participants
were given a participant information leaflet to read.
Trained research assistants explained the leaflets to
patients who were not literate. Participants who agreed
to participate in the study then completed a consent
form. Thereafter, the questionnaire was administered.
Recruitment continued over a period of one week, when
the required 500 participants were recruited. Critically
ill patients, those younger than 18 years old and those
who did not give consent were excluded. In order to
minimize contamination from staff, only the facility
manager and the research team were aware of the nat-
ure of the study. All the attending clinicians were
blinded to the nature and aims of the study. Recruit-
ment and data collection were also done after the
patients had exited from the consulting rooms and at
locations away from the consulting rooms. In addition,
participants were advised not to discuss the study with
any staff members.
Data collection
The five “A"s (Ask, Assess, Advise, Assist, Arrange)
summarize the roles of health care practitioners in
managing smoking [18]. A semi-structured question-
naire was adapted from the Patient Exit Interview ques-
tionnaire, which has been validated as a good measure
of providers’ behaviour on smoking cessation interven-
tion [19]. In order to focus on the objectives of the
study, only two of the five “A"s (Ask and Advise) were
covered by the current questionnaire (Additional file 1).
The questionnaire collected information on participants’
demographics, their use of tobacco products, their
intention to quit tobacco use, participants’ reports on
having been screened for tobacco use (or not) and clini-
cians’ offer of cessation advice (if any). The main
presenting health problem was extracted from the
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sures were participants’ self-reports of being screened
and advised to quit tobacco use by the attending clini-
cian, during the current clinic visit and during any other
visit in the last year.
Data analysis
Descriptive statistics of participants’ characteristics were
calculated, with categorical data presented as percen-
tages and continuous data presented as means with
standard deviations. Socio-demographic factors asso-
ciated with tobacco use status and the reporting of
screening were determined using t-tests (for continuous
data), the chi-square test (for categorical data) and Fish-
er’s exact test, where the expected cell count was less
than 5. In bi-variate analysis, the associations between
the presenting health problems and being screened dur-
ing the current clinic visit or during a prior visit within
the last year were determined. Significant correlates of
tobacco use and tobacco screening in all bi-variate ana-
lyses were then entered into two separate multiple logis-
tic regression models, in order to determine factors
which are independently associated with being screened
for tobacco use during the current visit or prior clinic
visits within the last year. Group differences were con-
sidered statistically significant when p values were lower
than 0.05.
Ethics and permission
Ethics clearance was obtained from the Human
Research Ethics Committee of the University of the Wit-
watersrand [Protocol number M080514], and permission
to conduct the study was granted by the Sedibeng Dis-
trict Health Services.
Results
Five hundred (500) participants completed the question-
naire, of whom 89% (n = 444) were Black and 11% (n =
55) were from other population groups, mainly White.
Of the participants, 26.8% (n = 134) were current
tobacco users and 6.5% were ex-users. Further analysis
showed that 14.8% (n = 74) were current smokers
(37.7% of men and 7.5% of women) and that 12.0% (n =
60) were SLT users (1.6% of men and 15.4% of women).
The mean number of cigarettes smoked daily was 7.3,
while SLT was used about 2.8 times per day. Other
characteristics of the participants are shown in Table 1.
Only 12.9% (n = 63) of the participants reported hav-
ing been screened for tobacco use during the current
visit and 10.6% (n = 53) reported that they had been
screened during prior visits within the last year. Of
those who reported that they had been screened during
the current visit, 10.4% (n = 14) were current tobacco
users. The proportions of tobacco users who reported
having been screened during the current or prior clinic
visits were not significantly different from the propor-
tions of non-users who reported having been screened
at similar clinic visits (see Table 2).
Of the participants who had not been screened, 88%
(n = 396) indicated they would be ‘very comfortable’
with being screened for tobacco use. Although 78.3%
(n = 94) of tobacco users said they intended to quit
tobacco use in the next six months, the proportion of
tobacco users at this stage of behavioral change was not
significantly associated with reporting being screened or
not screened during the current visit (66.7% vs. 79.4%;
p = 0.29), nor with reporting being screened or not
Table 1 Study participants’ characteristics (NB: All n did
not add up to 500 because of missing data)
Characteristics %(n) Mean (SD)
Age (years) 47.9 ±17.0
Sex
Female 75.5 (376)
Male 24.5 (122)
Race
Blacks 89.0 (444)
Other (non-Blacks) 11 (55)
Marital status
Single/never married 35.6 (176)
Divorced/separated/widowed 19.0 (94)
Married 45.3 (224)
Educational achievement
Less than Grade 12 75.2 (375)
Grade 12 and above 24.8 (124)
Current cigarette smokers 14.8 (74)
Current snuff users 12.0 (60)
Number of cigarettes per day 7.3 ±5.9
Smokeless tobacco use per day 2.8 ±1.7
Presenting health problem
Cardiovascular disease 50.2 (250)
HIV-related care 12.2 (61)
Pregnancy-related care 18.5 (92)
Other 19.1 (95)
Attending clinician
Medical practitioner 57.7 (287)
Nurse clinician 42.3 (210)
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80.2%; p = 0.20). Reporting being screened during the
current visit was also associated with reporting being
screened within the last year (p < 0.001). Other socio-
demographic correlates of tobacco use and screening are
shown in Table 2.
Of the 134 current tobacco users, 11.94% (n = 16)
reported being advised about the cessation of tobacco
use during the current clinic visit, while 35.1% (n = 47)
reported being advised about it during prior visits within
the last year. Of the 47 tobacco users who reported that
they had been advised during prior clinic visits, 13
Table 2 Socio-demographic correlates of tobacco use and reporting receiving tobacco screening
Socio-demographic variable % (n)
Smoking
% (n)
Snuff
%(n) screened during current visit %(n) screened during a prior visit
Current visit screening
No 15.0 (64) 12.9 (55) -
Yes 15.9 (10) 6.3 (4) -
p = 0.86 0.14
Prior visit screening
No 14.6 (65) 12.6 (56) 10.6 (46) -
Yes 17.0 (9) 7.5 (4) 32.1 (17) -
p = 0.65 0.38 <0.001 -
Sex
Female 7.4 (28) 15.4 (58) 14.1 (52) 11.2 (42)
Male 37.7 (46) 1.6 (2) 9.1 (11) 9.1 (11)
p = <0.001 <0.001 0.15 0.52
Race
Black 11.9 (53) 13.5 (60) 13.3 (58) 9.5 (42)
Other 38.2 (21) 0 9.3 (5) 20.0 (11)
p = 0.49 0.01 0.40 0.02
Educational level
Less than Grade 12 15.5 (58) 14.4 (54) 9.6 (35) 8.3 (31)
Grade 12 and higher education 12.9 (16) 4.8 (6) 22.6 (28) 17.7 (22)
p = 0.49 0.01 <0.001 <0.01
Marital status
Single 11.9 (21) 10.8 (19) 18.4 (32) 15.3 (27)
Separated/divorced/widowed 20.2 (19) 14.9 (14) 7.8 (7) 4.3 (4)
Married 14.7 (33) 11.2 (25) 10.9 (24) 9.9 (22)
p = 0.19 0.57 0.02 0.02
Current smoker
No - 12.7 (53) 10.4 (44)
Yes - 13.5 (10) 12.2 (9)
p = 0.86 0.65
Snuff user
No - 13.7 (59) 11.2 (49)
Yes - 6.8 (4) 6.7 (4)
p = 0.21 0.38
Attending clinician
Medical practitioner 20.2 (58) 11.0 (23) 5.7 (16) 8.0 (23)
Nurse clinician 7.6 (16) 12.5 (36) 22.8 (47) 14.3 (30)
p = 0.001 0.59 <0.001 0.03
Presenting health problem
HIV-related problem 14.8 (9) 14.8 (9) 10.0 (6) 9.8 (6)
Pregnancy-related problem 3.3 (3) 3.3 (3) 40.7 (37) 22.8 (21)
Cardiovascular disease 14.8 (37) 14.4 (36) 3.7 (9) 6.8 (17)
Other 26.3 (25) 12.6 (12) 11.6 (11) 8.4 (8)
p = <0.001 0.04 <0.001 <0.001
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current clinic visit. Among tobacco users, 81.5% (n =
101) reported that it was important to be advised
against tobacco use, while 85.9% (n = 110) reported that
they thought providing cessation advice could assist
them in quitting tobacco use.
In the final logistic regression models (Table 3), being
screened during a prior clinic visit in the last year
remained independently associated with tobacco use
screening during the current visit (OR = 2.65; 95%CI =
1.26-5.54). Compared to any other presenting health
problems, a pregnancy-related visit was the single most
significant factor associated with being screened for
tobacco use during the most recent clinic visit (OR =
4.59; 95%CI = 2.13-9.88).
Discussion
This study is one of very few studies documenting
patients’ report of clinicians’ behavior regarding tobacco
cessation activities in a PHC setting in South Africa.
The results show that opportunities provided by the
clinical encounter for screening and providing tobacco
use cessation advice were largely missed by clinicians.
The results confirm the findings of a qualitative study of
health care practitioners elsewhere in South Africa,
which found that few clinicians addressed their patients’
tobacco use habits [12]. The lack of doctors’ interven-
tion in patients’ tobacco habits in South Africa is con-
trary to what pertains in other countries such as
Australia, the USA and China, where physicians are
reported to be more engaged in activities targeting
patients’ tobacco use [20-22]. The poor engagement of
clinicians with tobacco intervention activities may reflect
clinicians’ failure to recognize the potential for such
interventions within the clinical consultation in reducing
rates of tobacco use, in addition to those already
achieved through policy interventions such as tax
increases and advertisement bans in South Africa. Inten-
sifying clinicians’ engagement in tobacco cessation activ-
ities in South Africa is crucial for a successful tobacco
control program, especially since the report of the
recent SADHS found that the prevalence of tobacco use
among men has been only slightly reduced and has
remained virtually stagnant among women and young
people since the last SADHS in 1999 [2].
Brief advice during clinical encounters (typically no
longer than 5 minutes) has been shown to be more
effective than “no advice” in increasing quitting rates
among tobacco users [12]; and the role(s) of health pro-
fessionals in helping their patients to quit is well recog-
nized [16]. However, a large proportion of participants
in this study were not advised against tobacco use, pos-
sibly due to barriers which have previously been docu-
mented [15,16], namely time constraints, a lack of
counseling skills, a lack of guidelines and protocols, the
absence of economic re-imbursement, the belief that
brief advice is not effective, the perception that it is not
a clinician’s responsibility to help clients to quit, the
belief that patients are not motivated to quit and reluc-
tance to jeopardize the doctor-patient relationship by
giving advice perceived to be unwelcome [16,23-25].
Whether these barriers apply in the South African con-
text is not yet known and further studies are needed to
determine this. Nevertheless, training health care practi-
tioners in tobacco cessation counseling is crucial and
has been shown to improve both counseling rates and
the quality of support given to patients who want to
quit cigarette smoking [26,27].
Regular tobacco use screening and brief advice should
result in more participants’ contemplating quitting, but
the findings of this study do not support this assump-
tion. Screening (during the current visit or in the last
Table 3 Final logistic regression model of factors associated with receiving tobacco use screening
Explanatory variable Screened during current visit [OR (95% CI)] Screened during prior visit [OR (95% CI)]
Age (continuous) - 0.96 (0.95 - 0.98)
Race
Non-Black - 1
Black 0.24 (0.11 - 0.54)
Presenting health problem
Other 1
Cardiovascular disease 0.30 (0.12 - 0.75) -
HIV-related problem 0.85 (0.29 - 2.45)
Pregnancy-related visit 4.59 (2.13 - 9.88)
Past screening experience
Never/rarely 1
Screened at prior visits 2.65 (1.26 - 5.54) -
n = 488, Nagelkerke R
2 = 0.27
Model fit (Hosmer & Lemeshow X
2) P = 0.91
n = 497, R
2 = 0.11
Model fit (Hosmer & Lemeshow X
2 test) = 0.97
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state of contemplating quitting (p = 0.21 and p = 0.09
for the current and the last year respectively). A possible
explanation for this observation could be that when
clinicians screen patients they do not follow up with
cessation advice, a key motivation for tobacco users to
contemplate quitting tobacco use.
The vast majority (88%) of the participants who had
not been screened stated that they would be “very com-
fortable” with tobacco use screening, while 78.3% of
tobacco users intended to quit within the next six
months. These findings are similar to findings from pre-
vious national surveys in South Africa [28] and they
highlight the scale of missed opportunities in interven-
ing in patients’ tobacco use.
The majority of tobacco users (81.5%) knew the
importance of being advised and reported that being
advised could help them quit tobacco use. Since smo-
kers have been documented to respond favorably to
their physicians’ advice, [29] not screening patients for
and advising patients against tobacco use constitute ser-
ious omissions, with both clinical and public health
implications. Screening and providing brief cessation
advice improve the probability of patients’ quitting
tobacco use and has the potential to decrease the several
thousand deaths from tobacco use, allowing for a
rechanneling of resources expended on the treatment of
tobacco-related diseases to other more pressing health
needs, such as HIV and AIDS treatment. These gains of
the anti-tobacco campaign at the public health level are
being lost due to these missed opportunities in the clini-
cal setting.
Given the well-documented adverse effects of tobacco
on the fœtus and the concerning report that up to 20%
and 10% of South African women smoke or use SLT
respectively during pregnancy, [15,30], it is a welcome
finding that participants attending the Centre for preg-
nancy-related conditions were more likely to have been
screened for tobacco use, compared to those presenting
with any other condition. Although pregnant patients
were attended to almost exclusively by midwives in the
current research setting, it would appear that the usual
practice of documenting (checking off) patients’ tobacco
use status on the antenatal card during pregnancy-
related visits is responsible for the above finding, rather
than the grade of the attending clinician. In fact, the
grade of the attending clinician was not significantly
associated with reporting being screened when potential
confounders were controlled for. Including tobacco use
status as a vital sign (as done on the antenatal card) has
indeed been shown to improve both tobacco use screen-
ing and clinicians’ offer of cessation advice [31]. There-
fore, setting up systems such as these that prompt
clinicians to document patients’ tobacco use status may
be an important strategy that could be considered in the
South African PHC settings for the promotion of
tobacco screening and intervention [32].
Illnesses offer “teachable” moments, during which
patients heed advice more readily and the knowledge of
serious diagnoses such as cardiovascular diseases results in
higher quit rates for tobacco use [33,34]. Despite the fact
that more than half (50.2%) of the participants in the cur-
rent study consulted their clinicians for cardiovascular-
related problems, this diagnosis was not associated with
reporting being screened for tobacco use. This is a cause
for serious concern in South Africa, as the country is cur-
rently undergoing a disease transition in which there is an
increase in the burden of cardiovascular diseases. In
addressing this concern, it should be recognized that the
monthly visits of chronic patients to their PHC clinics (for
check-ups, collection or renewal of medications) provide
opportunities for screening for, advising and reinforcing
previous advice on tobacco cessation. Unfortunately, these
opportunities were largely missed by clinicians in this
study. Stopping tobacco use is a difficult endeavor and
often requires many counseling attempts. Reinforcing ces-
sation advice as a way of intensifying the delivery of coun-
seling is a strategy that has been shown to improve the
cessation success rate [14] and should be employed to
enhance the odds of patients’ successfully quitting. Regret-
tably, patient contacts were not used to reinforce previous
advice, as only just over a quarter of the participants who
had been advised to quit in the last year were re-advised
to do so during the current clinic visit.
The cessation of all forms of tobacco use improves
health outcomes. Thus interventions which enable
tobacco users to achieve life-long abstinence must be
regarded as clinical and public health priorities [35].
While screening and advising do not guarantee success-
ful quitting, they assist clinicians in identifying tobacco
users and provide platforms for further cessation inter-
ventions, such as providing more intense advice and
referring to specialized services or national quit-lines.
The convenience sample used in this study may not
be representative of the entire clinic population, because
of possible selection bias. Since this study did not use a
nationally representative sample, caution must be exer-
cised in generalizing the findings of this study to all
patient visits in South Africa. However, the rates of
tobacco use among participants in the current study
approximate recent national estimates [2]. In the current
study, the smoking prevalence among men was slightly
higher at 37.7%, compared with a national prevalence of
35%. The smoking prevalence among women was how-
ever, slightly lower at 7.5%, compared to a national esti-
mate of 10%. Similarly, 1.6% of men (compared to a
national prevalence of 3%) and 15.4% of women (com-
pared to a national prevalence of 12%) used SLT.
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of tobacco cessation interventions (Ask and Advise),
because of the exploratory nature of the study, and the
recognition that many clinicians in South Africa do not
yet provide comprehensive clinical interventions for
tobacco users. Barriers to cessation counseling and the
extent to which these barriers influence clinicians’
behaviors were not investigated. These will be the
focus of a qualitative study currently being conducted
by the authors. Given that people tend to report favor-
able behavior when they are interviewed about a
socially undesirable behavior such as tobacco use, reli-
ance on participants’ self-reports can potentially lead to
information bias and a high rate of misclassification.
Considering the objectives of the current study, we do
not think that changing the study design will produce
significantly different results from the ones we have
reported in this article. Notwithstanding these limita-
tions, this study (one of the very few documenting
PHC clinicians’ tobacco screening and advising beha-
viors) provides useful information to develop tobacco
cessation programs and to study tobacco cessation in
South Africa further.
Conclusion
Despite participants’ claim that they would be comforta-
ble with tobacco use screening and cessation advice, only
a small proportion of the participants were screened and
advised against tobacco use. Regular clinic visits were not
used to reinforce previous tobacco cessation advice
among tobacco users. The magnitude of missed opportu-
nities documented in this study threatens tobacco control
efforts in South Africa and undermines the important
role that PHC practitioners c a np l a yi nf u r t h e rr e d u c i n g
the prevalence of tobacco use in South Africa.
Pregnancy-related visits increased the likelihood of
being screened for tobacco use, probably because
tobacco use status is included in the list of vital signs on
the antenatal card in South Africa. Extending this strat-
egy to all PHC patient-visits has the potential to compel
clinicians to screen all patients for tobacco use and may
consequently improve screening and intervention rates.
Further studies which focus on understanding why
PHC clinicians in South Africa do not intervene in their
patients’ tobacco use are needed in order to implement
effective tobacco cessation programs.
Additional material
Additional file 1: Patient exit questionnaire. The questionnaire used in
this current study.
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